{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:04:15Z","timestamp":1783793055029,"version":"3.55.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["1084927"],"award-info":[{"award-number":["1084927"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019999","name":"Trish Multiple Sclerosis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.neurot.2024.e00432","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T10:03:11Z","timestamp":1724061791000},"page":"e00432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis"],"prefix":"10.1016","volume":"21","author":[{"given":"James B.W.","family":"Hilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kysenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Liddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Rautengarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gojko","family":"Buncic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona A.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley I.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7777-4747","authenticated-orcid":false,"given":"Peter J.","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neurot.2024.e00432_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.12998\/wjcc.v3.i7.545","article-title":"Treatment strategies for multiple sclerosis: when to start, when to change, when to stop?","volume":"3","author":"Gajofatto","year":"2015","journal-title":"World J Clin Cases"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00432_bib2","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P\u00a0T"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00432_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00432_bib4","article-title":"Ocrelizumab for multiple sclerosis","volume":"5","author":"Lin","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00432_bib5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(20)30342-2","article-title":"Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial","volume":"19","author":"Wolinsky","year":"2020","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00432_bib6","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/brain\/awy088","article-title":"Progression of regional grey matter atrophy in multiple sclerosis","volume":"141","author":"Eshaghi","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00432_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ana.24241","article-title":"Spinal cord gray matter atrophy correlates with multiple sclerosis disability","volume":"76","author":"Schlaeger","year":"2014","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00432_bib8","doi-asserted-by":"crossref","first-page":"e1561","DOI":"10.1212\/WNL.0000000000011494","article-title":"Association of gray matter atrophy patterns with clinical phenotype and progression in multiple sclerosis","volume":"96","author":"Rocca","year":"2021","journal-title":"Neurology"},{"issue":"Pt 12","key":"10.1016\/j.neurot.2024.e00432_bib9","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1093\/brain\/awr278","article-title":"Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla","volume":"134","author":"Bagnato","year":"2011","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00432_bib10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3174\/ajnr.A0646","article-title":"Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging","volume":"28","author":"Ge","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00432_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jmri.21676","article-title":"Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging","volume":"29","author":"Haacke","year":"2009","journal-title":"J\u00a0Magn Reson Imag"},{"key":"10.1016\/j.neurot.2024.e00432_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102426","article-title":"Copper concentration in multiple sclerosis: a systematic review and meta-analysis","volume":"45","author":"Sarmadi","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00432_bib13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41419-018-0379-2","article-title":"Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review","volume":"9","author":"Sheykhansari","year":"2018","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00432_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/NEN.0b013e3181e3de90","article-title":"Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features","volume":"69","author":"Xie","year":"2010","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neures.2011.10.002","article-title":"Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication","volume":"72","author":"Steelman","year":"2012","journal-title":"Neurosci Res"},{"issue":"27","key":"10.1016\/j.neurot.2024.e00432_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025804118","article-title":"Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes","volume":"118","author":"Colombo","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"86","key":"10.1016\/j.neurot.2024.e00432_bib17","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice","author":"Bittner","year":"2014","journal-title":"J\u00a0Vis Exp"},{"issue":"23","key":"10.1016\/j.neurot.2024.e00432_bib18","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1039\/B307499D","article-title":"Structural trends in copper(II) bis(thiosemicarbazone) radiopharmaceuticals","author":"Blower","year":"2003","journal-title":"Dalton T"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00432_bib19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1139\/v62-161","article-title":"Preparation of some thiosemicarbazones and their copper complexes .3","volume":"40","author":"Gingras","year":"1962","journal-title":"Can J Chem"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfad072","article-title":"Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice","volume":"16","author":"Hilton","year":"2024","journal-title":"Metallomics"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00432_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00216-018-1362-6","article-title":"A\u00a0versatile quantitative microdroplet elemental imaging method optimised for integration in biochemical workflows for low-volume samples","volume":"411","author":"Kysenius","year":"2019","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.neurot.2024.e00432_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuroimage.2016.05.057","article-title":"Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex","volume":"137","author":"Hare","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurot.2024.e00432_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.freeradbiomed.2014.01.041","article-title":"Ceruloplasmin and beta-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron","volume":"69","author":"Ayton","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00432_bib24","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.bbagen.2014.08.006","article-title":"A\u00a0comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe(2+) under physiologically relevant conditions","volume":"1840","author":"Wong","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neurot.2024.e00432_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/bs.mcb.2017.08.009","article-title":"Measurement of lysyl oxidase activity from small tissue samples and cell cultures","volume":"143","author":"Trackman","year":"2018","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.neurot.2024.e00432_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinf"},{"issue":"6556","key":"10.1016\/j.neurot.2024.e00432_bib27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abg1134","article-title":"Lifetime mobility of an Arctic woolly mammoth","volume":"373","author":"Wooller","year":"2021","journal-title":"Science"},{"issue":"30","key":"10.1016\/j.neurot.2024.e00432_bib28","doi-asserted-by":"crossref","first-page":"10321","DOI":"10.1039\/D1SC02237G","article-title":"An integrated mass spectrometry imaging and digital pathology workflow for objective detection of colorectal tumours by unique atomic signatures","volume":"12","author":"Paul","year":"2021","journal-title":"Chem Sci"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00432_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ana.21719","article-title":"Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"66","author":"Vogt","year":"2009","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/mrm.25420","article-title":"Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: interpreting positive susceptibility and the presence of iron","volume":"74","author":"Wisnieff","year":"2015","journal-title":"Magn Reson Med"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00432_bib31","first-page":"1003","article-title":"Hephaestin and ceruloplasmin play distinct but interrelated roles in iron homeostasis in mouse brain","volume":"145","author":"Jiang","year":"2015","journal-title":"J\u00a0Nutr"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13770-016-0007-0","article-title":"The role of the lysyl oxidases in tissue repair and remodeling: a concise review","volume":"14","author":"Cai","year":"2017","journal-title":"Tissue Eng Regen Med"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2010-1359","article-title":"Bis(thiosemicarbazonato) Cu-64 complexes for positron emission tomography imaging of Alzheimer's disease","volume":"20","author":"Fodero-Tavoletti","year":"2010","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"51","key":"10.1016\/j.neurot.2024.e00432_bib34","doi-asserted-by":"crossref","first-page":"44035","DOI":"10.1074\/jbc.M111.274407","article-title":"Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model","volume":"286","author":"Soon","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00432_bib35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.20112285","article-title":"The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease","volume":"209","author":"Hung","year":"2012","journal-title":"J\u00a0Experi Med"},{"issue":"7-8","key":"10.1016\/j.neurot.2024.e00432_bib36","first-page":"586","article-title":"Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis","volume":"14","author":"McAllum","year":"2013","journal-title":"Amyotro Lat Scler Front Deg"},{"issue":"23","key":"10.1016\/j.neurot.2024.e00432_bib37","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1523\/JNEUROSCI.4196-13.2014","article-title":"Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"34","author":"Roberts","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.neurot.2024.e00432_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.01.020","article-title":"Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD","volume":"89","author":"Williams","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurot.2024.e00432_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/srep42292","article-title":"Cu(II)(atsm) improves the neurological phenotype and survival of SOD1(G93A) mice and selectively increases enzymatically active SOD1 in the spinal cord","volume":"7","author":"Hilton","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2024.e00432_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ibror.2017.03.001","article-title":"CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits","volume":"2","author":"Vieira","year":"2017","journal-title":"IBRO Rep"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s13311-016-0504-9","article-title":"The copper bis(thiosemicarbazone) complex Cu(II)(atsm) is protective against cerebral ischemia through modulation of the inflammatory milieu","volume":"14","author":"Huuskonen","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2024.e00432_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104495","article-title":"Neuroprotective effect of CuATSM on neurotoxin-induced motor neuron loss in an ALS mouse model","volume":"130","author":"Kuo","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00432_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160158","article-title":"Inhibition of vascular endothelial growth factor receptor 2 exacerbates loss of lower motor neurons and axons during experimental autoimmune encephalomyelitis","volume":"11","author":"Stanojlovic","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00432_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jnr.23528","article-title":"Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis","volume":"93","author":"Pryor","year":"2015","journal-title":"J\u00a0Neurosci Res"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00432_bib45","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.bbadis.2013.09.005","article-title":"MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"1832","author":"Mao","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00432_bib46","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4065\/81.10.1371","article-title":"Copper deficiency myelopathy (human swayback)","volume":"81","author":"Kumar","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00432_bib47","first-page":"869","article-title":"Copper deficiency myelopathy","volume":"257","author":"Jaiser","year":"2010","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ncpneuro1008","article-title":"When metals compete: a case of copper-deficiency myeloneuropathy and anemia","volume":"5","author":"Spain","year":"2009","journal-title":"Nat Clin Pract Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archneur.1976.00500020039007","article-title":"Hypomyelination in copper-deficient rats. Prenatal and postnatal copper replacement","volume":"33","author":"Zimmerman","year":"1976","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0024-3205(67)90356-6","article-title":"Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity","volume":"6","author":"Carlton","year":"1967","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib51","first-page":"307","article-title":"Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone)","volume":"54","author":"Suzuki","year":"1969","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-510X(73)90118-4","article-title":"Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone","volume":"20","author":"Blakemore","year":"1973","journal-title":"J\u00a0Neurol Sci"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00432_bib53","first-page":"597","article-title":"Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity","volume":"39","author":"Ludwin","year":"1978","journal-title":"Lab Invest"},{"key":"10.1016\/j.neurot.2024.e00432_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","article-title":"The cuprizone model for demyelination","volume":"188","author":"Torkildsen","year":"2008","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.neurot.2024.e00432_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neurot.2024.e00432_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/17590914221126367","article-title":"Cuprizone-induced demyelination in mouse brain is not due to depletion of copper","volume":"14","author":"Morgan","year":"2022","journal-title":"Asn Neuro"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00432_bib57","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1973.tb07569.x","article-title":"Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cuprizone treatment in vivo","volume":"21","author":"Venturini","year":"1973","journal-title":"J\u00a0Neurochem"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00432_bib58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ejhg.2009.187","article-title":"Menkes disease","volume":"18","author":"Tumer","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ng1094-195","article-title":"Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus","volume":"8","author":"Kaler","year":"1994","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00432_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajhg.2010.01.027","article-title":"Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy","volume":"86","author":"Kennerson","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/abio.1994.1408","article-title":"Long-term measurement of organ copper turnover in rats by continuous feeding of a stable isotope","volume":"221","author":"Levenson","year":"1994","journal-title":"Anal Biochem"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00432_bib62","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1039\/C6MT00099A","article-title":"Endogenous Cu in the central nervous system fails to satiate the elevated requirement for Cu in a mutant SOD1 mouse model of ALS","volume":"8","author":"Hilton","year":"2016","journal-title":"Metallomics"},{"key":"10.1016\/j.neurot.2024.e00432_bib63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.expneurol.2018.06.006","article-title":"The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1(G37R) mouse model of ALS and can be restored by overexpressing the human copper transporter hCTR1","volume":"307","author":"Hilton","year":"2018","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","article-title":"Wilson's disease and other neurological copper disorders","volume":"14","author":"Bandmann","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib65","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1038\/s41598-024-55832-w","article-title":"Evidence for disrupted copper availability in human spinal cord supports Cu(II)(atsm) as a treatment option for sporadic cases of ALS","volume":"14","author":"Hilton","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J\u00a0Neurol Sci"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00432_bib67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneurol.2014.118","article-title":"Iron in multiple sclerosis: roles in neurodegeneration and repair","volume":"10","author":"Stephenson","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00432_bib68","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/awab059","article-title":"The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis","volume":"144","author":"Ghorbani","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2024.e00432_bib69","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbi.2021.02.030","article-title":"The distinct roles of monoamines in multiple sclerosis: a bridge between the immune and nervous systems?","volume":"94","author":"Carandini","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00432_bib70","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease","volume":"73","author":"Ayton","year":"2013","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib71","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00401-017-1726-6","article-title":"Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson's disease brain","volume":"134","author":"Trist","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00432_bib72","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/bph.14881","article-title":"Cu(II) (atsm) inhibits ferroptosis: implications for treatment of neurodegenerative disease","volume":"177","author":"Southon","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13024-023-00691-8","article-title":"Microglial ferroptotic stress causes non-cell autonomous neuronal death","volume":"19","author":"Liddell","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.msard.2011.09.001","article-title":"Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse","volume":"1","author":"Al-Izki","year":"2012","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00432_bib75","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1172\/JCI33464","article-title":"Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis","volume":"118","author":"Basso","year":"2008","journal-title":"J\u00a0Clin Invest"},{"issue":"6586","key":"10.1016\/j.neurot.2024.e00432_bib76","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00432_bib77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1073\/pnas.1116227108","article-title":"An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII","volume":"109","author":"Donnelly","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib78","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.mito.2009.01.011","article-title":"PET imaging of redox and energy states in stroke-like episodes of MELAS","volume":"9","author":"Ikawa","year":"2009","journal-title":"Mitochondrion"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00432_bib79","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nucmedbio.2011.02.016","article-title":"Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET","volume":"38","author":"Ikawa","year":"2011","journal-title":"Nucl Med Biol"},{"issue":"20","key":"10.1016\/j.neurot.2024.e00432_bib80","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1212\/WNL.0000000000001588","article-title":"Increased oxidative stress is related to disease severity in the ALS motor cortex: a PET study","volume":"84","author":"Ikawa","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00432_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11051022","article-title":"Cerebral oxidative stress in early alzheimer's disease evaluated by (64)Cu-atsm PET\/MRI: a preliminary study","volume":"11","author":"Okazawa","year":"2022","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nucmedbio.2011.08.008","article-title":"Radiolabeled Cu-ATSM as a novel indicator of over reduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less rho0 cells and cybrids carrying MELAS mitochondrial DNA mutation","volume":"39","author":"Yoshii","year":"2012","journal-title":"Nucl Med Biol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00432_bib83","first-page":"193","article-title":"Assessing tumor hypoxia by positron emission tomography with Cu-ATSM","volume":"53","author":"Holland","year":"2009","journal-title":"Q\u00a0J Nucl Med Mol Imag"},{"key":"10.1016\/j.neurot.2024.e00432_bib84","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2022.11.026","article-title":"Transdermal application of soluble Cu(II)(atsm) increases brain and spinal cord uptake compared to gavage with an insoluble suspension","volume":"509","author":"Nikseresht","year":"2023","journal-title":"Neuroscience"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:09:55Z","timestamp":1762560595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1878747924001181"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00432","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00432"}}